The PI3K-AKT-mTOR pathway and prostate cancer: at the crossroads of AR, MAPK, and WNT signaling

BY Shorning, MS Dass, MJ Smalley… - International journal of …, 2020 - mdpi.com
Oncogenic activation of the phosphatidylinositol-3-kinase (PI3K), protein kinase B
(PKB/AKT), and mammalian target of rapamycin (mTOR) pathway is a frequent event in …

Targeting the PI3K/AKT/mTOR signaling pathway in the treatment of human diseases: Current status, trends, and solutions

J Huang, L Chen, J Wu, D Ai, JQ Zhang… - Journal of medicinal …, 2022 - ACS Publications
The phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of
rapamycin (mTOR) pathway is one of the most important intracellular pathways involved in …

Molecular biomarkers in localized prostate cancer: ASCO guideline

SE Eggener, RB Rumble, AJ Armstrong… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE This guideline provides recommendations for available tissue-based prostate
cancer biomarkers geared toward patient selection for active surveillance, identification of …

PTEN regulates PI (3, 4) P2 signaling downstream of class I PI3K

M Malek, A Kielkowska, T Chessa, KE Anderson… - Molecular cell, 2017 - cell.com
The PI3K signaling pathway regulates cell growth and movement and is heavily mutated in
cancer. Class I PI3Ks synthesize the lipid messenger PI (3, 4, 5) P 3. PI (3, 4, 5) P 3 can be …

Phosphoinositides in new spaces

EM Davies, CA Mitchell… - Cold Spring Harbor …, 2023 - cshperspectives.cshlp.org
Phosphoinositides (PIs) are phospholipids derived from phosphatidylinositol. PIs are
regulated via reversible phosphorylation, which is directed by the opposing actions of PI …

INPP4B promotes PI3Kα-dependent late endosome formation and Wnt/β-catenin signaling in breast cancer

SJ Rodgers, LM Ooms, VMJ Oorschot… - Nature …, 2021 - nature.com
Abstract INPP4B suppresses PI3K/AKT signaling by converting PI (3, 4) P2 to PI (3) P and
INPP4B inactivation is common in triple-negative breast cancer. Paradoxically, INPP4B is …

PI (3, 4) P2 signaling in cancer and metabolism

L Gozzelino, MC De Santis, F Gulluni, E Hirsch… - Frontiers in …, 2020 - frontiersin.org
The phosphatidylinositide 3 kinases (PI3Ks) and their downstream mediators AKT and
mammalian target of rapamycin (mTOR) are central regulators of glycolysis, cancer …

Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases

SJ Rodgers, DT Ferguson, CA Mitchell… - Bioscience …, 2017 - portlandpress.com
Class I phosphoinositide 3-kinase (PI3K) generates phosphatidylinositol 3, 4, 5-
trisphosphate (PtdIns (3, 4, 5) P 3) at the plasma membrane in response to growth factors …

Ubiquitin-specific protease 10 determines colorectal cancer outcome by modulating epidermal growth factor signaling via inositol polyphosphate-4-phosphatase type …

K Kubaichuk, T Seitz, U Bergmann, V Glumoff… - Oncogenesis, 2024 - nature.com
Although there have been advances in understanding colorectal cancer (CRC)
pathogenesis, significant gaps still exist, highlighting the need for deeper insights …

Regulation of PtdIns(3,4,5)P3/Akt signalling by inositol polyphosphate 5-phosphatases

MJ Eramo, CA Mitchell - Biochemical Society Transactions, 2016 - portlandpress.com
The phosphoinositide 3-kinase (PI3K) generated lipid signals, PtdIns (3, 4, 5) P 3 and PtdIns
(3, 4) P 2, are both required for the maximal activation of the serine/threonine kinase proto …